With HF in progress, AT II counteracts the inhibitory ADO effect on NHE3, leading to retention of Na+, which increases the osmolarity of the blood, and to a shift of fluid into the blood volume and extracellular space [37]. This evidence concerns the gene SLC9A3 and hydrops fetalis.